Kangmei Pharma | 600518 - Ebit

Aktienkurs
1.75
Täglich Wechseln
0 0%
Monatlich
-6.42%
Jährlich
-12.94%
Q2 Prognose
1.72




Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.39M 1.72M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Genomma Lab Internacional MXN 800.61M 167.16M 2025-12
Hypermarcas BRL 647.2M 23.33M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Jiangsu Hengrui CNY 2.25B 848.02M 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 28M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Sh Fosun Pharma CNY 864.14M 185.2M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Viatris USD -157.5M 392M 2025-12
Wuxi Apptec CNY 4.67B 73.59M 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 15.6M 2025-09